|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1998-10-8
|
|
pubmed:abstractText |
Resistance to antiviral therapy is getting actually more frequent. Immunocompromised host are more concerned with this problem.
|
|
pubmed:language |
fre
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0151-9638
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
125
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
127-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9747231-Acyclovir,
pubmed-meshheading:9747231-Antiviral Agents,
pubmed-meshheading:9747231-Drug Resistance, Microbial,
pubmed-meshheading:9747231-Foscarnet,
pubmed-meshheading:9747231-HIV Seronegativity,
pubmed-meshheading:9747231-Herpes Zoster,
pubmed-meshheading:9747231-Humans,
pubmed-meshheading:9747231-Immunocompromised Host,
pubmed-meshheading:9747231-Lymphoma, T-Cell,
pubmed-meshheading:9747231-Male,
pubmed-meshheading:9747231-Middle Aged
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
[Acyclovir-resistance zona in a immunocompromised HIV seronegative patient].
|
|
pubmed:affiliation |
Service de médecine interne 2, Hôpital Cochin, Paris.
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|
